Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Type 2 Diabetes Through Using Acceptance and Commitment Therapy Principles to Target Illness Perceptions and Controllability Awareness in Educational Materials

NCT05260983 is registered in ClinicalTrials.gov with University of Oregon as lead sponsor.

NCT NCT05260983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05260983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Type 2 Diabetes Through Using Acceptance and Commitment Therapy Principles to Target Illness Perceptions and Controllability Awareness in Educational Materials
Lead sponsor
University of Oregon
Phase
Not applicable
Overall status
Completed
Start date
August 28, 2021
Completion date
September 21, 2021
Enrollment
301 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2, diabetes type2, prediabetes